IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 50 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,877,119 | -15.7% | 36,168 | -2.7% | 0.02% | -15.8% |
| Q2 2023 | $2,227,814 | +42.2% | 37,155 | +17.3% | 0.02% | +35.7% |
| Q1 2023 | $1,566,210 | -10.6% | 31,679 | +3.2% | 0.01% | -12.5% |
| Q4 2022 | $1,751,764 | +55.7% | 30,695 | +28.1% | 0.02% | +45.5% |
| Q3 2022 | $1,125,000 | +18.2% | 23,958 | -6.1% | 0.01% | +22.2% |
| Q2 2022 | $952,000 | -28.0% | 25,526 | -42.3% | 0.01% | -35.7% |
| Q1 2022 | $1,322,000 | -23.8% | 44,226 | -12.7% | 0.01% | -30.0% |
| Q4 2021 | $1,735,000 | -12.8% | 50,670 | -5.6% | 0.02% | +5.3% |
| Q3 2021 | $1,989,000 | -11.1% | 53,663 | -6.3% | 0.02% | -5.0% |
| Q2 2021 | $2,237,000 | – | 57,273 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $34,592,303 | 27.53% |
| RTW INVESTMENTS, LP | 6,029,633 | $361,536,795 | 6.88% |
| Paradigm Biocapital Advisors LP | 1,270,124 | $76,156,635 | 5.88% |
| Rock Springs Capital Management LP | 3,028,410 | $181,583,464 | 4.32% |
| Logos Global Management LP | 500,000 | $29,980,000 | 4.08% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $24,319,776 | 3.58% |
| GREAT POINT PARTNERS LLC | 297,082 | $17,813,037 | 3.49% |
| Eschler Asset Management LLP | 34,000 | $2,038,640 | 2.89% |
| COWEN AND COMPANY, LLC | 460,036 | $27,583,758 | 2.29% |
| HighVista Strategies LLC | 44,094 | $2,643,876 | 1.21% |